Academic literature on the topic 'Nootropic drugs'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Nootropic drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Nootropic drugs"

1

Mishchenko, O. Ya, N. Yu Palagina, O. L. Khaleeva та Yu I. Greshko. "Analysis of the assortment and economic affordability of noоtropic drugs". Social Pharmacy in Health Care 7, № 1 (2021): 80–86. http://dx.doi.org/10.24959/sphhcj.21.216.

Full text
Abstract:
Aim. To analyze the range and assess the economic availability of nootropic drugs at the Ukrainian pharmaceutical market in 2018.
 Materials and methods. The study object was information about nootropic drugs available at the pharmaceutical market of Ukraine in 2018 based on the data of the “PharmXplorer” analytical system of the information retrieval company “Morion”. The study included drugs used for the treatment of cerebrovascular diseases from the N06B X pharmacotherapeutic group (according to the ATC classification) – “Other psychostimulative and nootropic drugs”. An indicator of th
APA, Harvard, Vancouver, ISO, and other styles
2

Malík, Matěj, and Pavel Tlustoš. "Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs." Nutrients 14, no. 16 (2022): 3367. http://dx.doi.org/10.3390/nu14163367.

Full text
Abstract:
Nootropics, also known as “smart drugs” are a diverse group of medicinal substances whose action improves human thinking, learning, and memory, especially in cases where these functions are impaired. This review provides an up-to-date overview of the potential effectiveness and importance of nootropics. Based on their nature and their effects, this heterogeneous group of drugs has been divided into four subgroups: classical nootropic compounds, substances increasing brain metabolism, cholinergic, and plants and their extracts with nootropic effects. Each subgroup of nootropics contains several
APA, Harvard, Vancouver, ISO, and other styles
3

Vitthalrao, Leena Sakhare. "NOOTROPICS AGENTS: PHARMACEUTICAL ASPECT, COMMON EXAMPLES AND THEIR APPLICATIONS." Journal of Drug Delivery and Therapeutics 8, no. 5-s (2018): 59–61. http://dx.doi.org/10.22270/jddt.v8i5-s.1940.

Full text
Abstract:
Nootropics compounds are one of the important categories of medicinal agents act as cognitive enhancers and neuroprotective. These agents mainly used to improve memory related functioning of brain. Nootropic compounds exhibited various neural activities and boost functioning of central nervous system including improvement of intellectual, memory and learning capacity. These agents also offer significant relief in various neurodegenerative disorders such as parkinson disease and alzheimer disease. Drugs, nutraceuticals, supplements and functional foods may be used as nootropics agents to enhanc
APA, Harvard, Vancouver, ISO, and other styles
4

Suliman, Noor Azuin, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, and Rusliza Basir. "Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–12. http://dx.doi.org/10.1155/2016/4391375.

Full text
Abstract:
Nootropics or smart drugs are well-known compounds or supplements that enhance the cognitive performance. They work by increasing the mental function such as memory, creativity, motivation, and attention. Recent researches were focused on establishing a new potential nootropic derived from synthetic and natural products. The influence of nootropic in the brain has been studied widely. The nootropic affects the brain performances through number of mechanisms or pathways, for example, dopaminergic pathway. Previous researches have reported the influence of nootropics on treating memory disorders
APA, Harvard, Vancouver, ISO, and other styles
5

Priyavarshini R, Shweta Betala, and Amit B Patil. "Formulation and Evaluation of fixed dose combination of Nootropic drugs." International Journal of Research in Pharmaceutical Sciences 11, no. 3 (2020): 2895–908. http://dx.doi.org/10.26452/ijrps.v11i3.2374.

Full text
Abstract:
Cognitive functions are the critical brain functions responsible for the effective learning and understanding in the humans. They are responsible for various functions like attention, memory, reasoning and in turn helps to improve knowledge. Cognitive impairment is majorly seen in elderly as the brain is prone to neuro degradation. It may also occur in young adults due to poor diet or exercise. Improving cognition is of utmost importance and can be done by the use of cognition enhancers like Nootropics. This class of drugs is said to act by various mechanisms, which in turn leads to the better
APA, Harvard, Vancouver, ISO, and other styles
6

Voronina, T. A. "Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects." Нейрохимия 40, no. 2 (2023): 121–31. http://dx.doi.org/10.31857/s102781332302019x.

Full text
Abstract:
The review provides information about the features of cognitive dysfunctions that occur in various diseases and conditions, and data on the history of the creation and characteristic features of nootropics. The review presents the mechanisms of action and the spectrum of pharmacological effects of nootropic drugs from various groups: drugs that affect brain metabolism, neurotransmitter systems (cholinergic, glutamatergic, gabaergic and others), cerebral vasodilators, neuropeptides and their analogues, antioxidants, membrane protectors and others. The free radical and mitochondrial concepts of
APA, Harvard, Vancouver, ISO, and other styles
7

Voronina, T. A. "Cognitive Impairment and Nootropic Drugs: Mechanism of Action and Spectrum of Effects." Neurochemical Journal 17, no. 2 (2023): 180–88. http://dx.doi.org/10.1134/s1819712423020198.

Full text
Abstract:
Abstract—This review provides information about the features of cognitive dysfunctions that occur in various diseases and conditions, and data on the history of the creation and characteristic features of nootropics. The review presents the mechanisms of action and the spectrum of pharmacological effects of nootropic drugs from various groups: drugs that affect brain metabolism, neurotransmitter systems (cholinergic, glutamatergic, GABAergic, and others), cerebral vasodilators, neuropeptides and their analogues, antioxidants, membrane protectors, and others. The free radical and mitochondrial
APA, Harvard, Vancouver, ISO, and other styles
8

Anton, Semenets, Suleiman Marharyta, Georgiyants Victoriya, et al. "Theoretical justification of a purposeful search of potential neurotropic drugs." ScienceRise: Pharmaceutical Science, no. 4(26) (August 31, 2020): 4–17. https://doi.org/10.15587/2519-4852.2020.210042.

Full text
Abstract:
A targeted search for potential drugs of neurotropic action involves the choice of a basic “pharmacophore”, which is advisable to carry out on the basis of the achieved principle among the classes of chemical compounds where active pharmaceutical substances with high targeted activity have already been identified. Therefore, the pyrrolidine core, which is the basic fragment of nootropics of the racetam group, is promising for the rational design of biologically active compounds of nootropic action. Its combination with other heterocyclic fragments, in particular, the 1,2,4-triazole
APA, Harvard, Vancouver, ISO, and other styles
9

Saiz Garcia, H., L. Montes Reula, A. Portilla Fernandez, et al. "Nootropics: Emergents drugs associated with new clinical challenges." European Psychiatry 41, S1 (2017): s877—s878. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1769.

Full text
Abstract:
IntroductionThe “nootropic” or simplified as a “smart drug”, is a common term that will tag along with the compound responsible for the enhancement of mental performance. Certain individuals with a history of mental or substance use disorders might be particularly vulnerable to its adverse effects.MethodologyA review was conducted aiming to clarify the mechanisms associated of how these drugs increase mental functions including memory, motivation, concentration, and attention; and which kind of individuals are at risk of developing adverse effects when taking these drugs. The literature search
APA, Harvard, Vancouver, ISO, and other styles
10

Arcadi, Francesca Antonia, Francesco Corallo, Michele Torrisi, et al. "Role of citicoline and choline in the treatment of post-stroke depression: an exploratory study." Journal of International Medical Research 49, no. 11 (2021): 030006052110550. http://dx.doi.org/10.1177/03000605211055036.

Full text
Abstract:
Objective To compare selective serotonin reuptake inhibitors (SSRIs) and nootropic drugs in the reduction of anxiety and depressive symptoms in post-stroke patients. Methods This retrospective cohort study included patients diagnosed with post-stroke depression that were treated with either SSRIs or nootropic drugs (i.e. citicoline or choline alphoscerate). Depression and anxiety were assessed using the Hamilton Rating Scales. Statistical associations between the use of nootropic drugs and mood disorder improvements were determined by measuring assessment scores at 6-months. Results A total of
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Nootropic drugs"

1

Fisher, Kim Noël. "Behavioural and physiological effects of two aniracetam analogues." Thesis, McGill University, 1994. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=22585.

Full text
Abstract:
The behavioural and electrophysiological consequences of two newly developed aniracetam analogues were investigated in male Long-Evans rats. Results indicate that an intraperitoneal (i.p.) injection of LD38.2 significantly improved retention in a two odour olfactory discrimination task. However, three different dosages of LN1 did not facilitate memory in the task. In rats with chronically implanted electrodes, both compounds rapidly crossed the blood brain barrier (BBB) after an i.p. injection and influenced several parameters of the field excitatory postsynaptic potential (EPSP) in the CA1 an
APA, Harvard, Vancouver, ISO, and other styles
2

Barnes, J. M. "Neurochemical assessments of the actions of novel agents having nootropic and anxiolytic potential." Thesis, University of Bradford, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.234701.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sanku, Rajesh Kishore kumar. "DEVELOPMENT AND BIOLOGICAL EVALUATION OF CARBONIC ANHYDRASE MODULATORS AS POTENTIAL NOOTROPICS AND ANTICANCER AGENTS." Diss., Temple University Libraries, 2018. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/487142.

Full text
Abstract:
Pharmaceutical Sciences<br>Ph.D.<br>Cancer is the second most common cause of death in the world. One of the objectives of this thesis is to biologically evaluate a series of anti-cancer polymeric aromatic/heterocyclic bis-sulfonamides and pyridinium sulfonamides which were synthesized from three established aminosulfonamide carbonic anhydrase (CA, EC 4.2.1.1) inhibitor pharmacophores. Testing of these novel inhibitors and their precursors against a panel of membrane-bound CA isoforms, including tumor-overexpressed CA IX and XII and cytosolic isozymes, identified nanomolar-potent inhibitors ag
APA, Harvard, Vancouver, ISO, and other styles
4

Krishnan, Vinu. "Design and Synthesis of Nanoparticle “PAINT-BRUSH” Like Multi-Hydroxyl Capped Poly(Ethylene Glycol) Conjugates for Cancer Nanotherapy." Akron, OH : University of Akron, 2008. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=akron1217677351.

Full text
Abstract:
Thesis (M.S.)--University of Akron, Dept. of Biomedical Engineering, 2008.<br>"August, 2008." Title from electronic thesis title page (viewed 12/9/2009) Advisor, Stephanie T. Lopina; Committee members, Amy Milsted, Daniel B. Sheffer, Daniel Ely; Department Chair, Daniel B. Sheffer; Dean of the College, George K. Haritos; Dean of the Graduate School, George R. Newkome. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
5

Seif, Taban. "D-cycloserine enhances postsynaptic excitability in vitro : novel and conserved nootropic mechanism /." 2007. http://proquest.umi.com/pqdweb?did=1445034881&sid=7&Fmt=2&clientId=10361&RQT=309&VName=PQD.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Garringer, Eva Marie. "Modlation of AMPA receptor desensitization by nootropic drugs and endogenous proteins." 2005. http://digital.library.okstate.edu/etd/umi-okstate-1307.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Nootropic drugs"

1

Polkovnikova, Yuliya. Liposomal forms of nootropic drugs. INFRA-M Academic Publishing LLC., 2023. http://dx.doi.org/10.12737/1959243.

Full text
Abstract:
The monograph summarizes the results of our own research in comparison with the literature data on the development of the composition and technology of liposomal dosage forms of nootropic action.&#x0D; It is intended for researchers in the field of pharmacy, biology and medicine, as well as for pharmacists, teachers, graduate students, residents and students engaged in scientific research.
APA, Harvard, Vancouver, ISO, and other styles
2

Heidrich, Heinz, ed. Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70786-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Potter, Beverly A. Brain boosters: Food & drugs that make you smarter. Ronin Pub., 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

John, Morgenthaler, and Fowkes Steven Wm, eds. Smart drugs II: The next generation : new drugs and nutrients to improve your memory and increase your intelligence. Health Freedom Publications, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dean, Ward. Smart drugs & nutrients: How to improve your memory and increase your intelligence using the latest discoveries in neuroscience. B&J Publications, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dean, Ward. Smart drugs and nutrients: How to improve your memory and increase your intelligence using the latest discoveries in neuroscience. B & J Publications, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mayell, Mark. Natural energy: A consumer's guide to legal, mind-altering, and mood-brightening herbs and supplements. Three Rivers Press, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pelton, Ross. Mind food & smart pills: A sourcebook for the vitamins, herbs, and drugs that can increase intelligence, improve memory, and prevent brain aging. Doubleday, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nicola, Canal, ed. Guidelines for drug trials in memory disorders. Raven Press, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Institute of Medicine (U.S.). Committee on Military Nutrition Research. Caffeine for the sustainment of mental task performance: Formulations for military operations. National Academy Press, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Nootropic drugs"

1

Poschel, B. P. H. "New Pharmacological Perspectives on Nootropic Drugs." In Handbook of Psychopharmacology. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-0933-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kanowski, S., G. Ladurner, K. Maurer, W. D. Oswald, and U. Stein. "Outline for the evaluation of nootropic drugs." In Key Topics in Brain Research. Springer Vienna, 1990. http://dx.doi.org/10.1007/978-3-7091-3396-5_61.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dolce, G., V. Cecconi, A. Zamponi, R. Zylberman, L. Maggi, and A. Battaglia. "Methodological Approach to the Clinical Evaluation of Nootropic Drugs." In Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70786-5_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pepeu, Giancarlo, Maria Grazia Giovannini, Ileana Marconcini Pepeu, and Luciano Bartolini. "Nootropic Drugs: The Gap Between Preclinical and Clinical Results." In Alzheimer Disease. Birkhäuser Boston, 1994. http://dx.doi.org/10.1007/978-1-4615-8149-9_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Voronina, Tatiana A. "Nootropic Drugs in Alzheimer Disease Treatment. New Pharmacological Strategies." In Alzheimer Disease. Birkhäuser Boston, 1994. http://dx.doi.org/10.1007/978-1-4615-8149-9_45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wertheimer, J. "Principles of Controlled Clinical Studies in Psychogeriatrics." In Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70786-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bolli, R. "Salutary Actions of Nicergoline During Experimental Coronary Artery Occlusion and Reperfusion." In Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70786-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ehrly, A. M. "A General Introduction to Haemorrheology and its Clinical Importance." In Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70786-5_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Di Perri, T., M. Guerrini, R. Cappelli, et al. "Effects of a Single I.V. Dose of Nicergoline on Haemorrheological and Haemodynamic Parameters in Peripheral Vascular Disease. A Double-Blind, Cross-over Study." In Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70786-5_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ehrly, A. M., and H. Landgraf. "The Effects of Nicergoline on the Filtrability of Hyperosmolar Blood." In Proof of Therapeutical Effectiveness of Nootropic and Vasoactive Drugs. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-70786-5_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Nootropic drugs"

1

Moriau, M., E. Lavenne-Pardonge, and C. H. Col-De Beys. "TREATMENT OF RAYNAUD SYNDROMES WITH PIRACETAM(NOOTROPIL R),NOOTROPIC AND ANIPLATELET AGENT." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643426.

Full text
Abstract:
Three prospective studies have been performed with piracetam (Nootropil ®-) in the treatment of Raynaud disease and syndromes.The first one, realized in 20 cases of Raynaud disease established that 8 g piracetam daily was the optimal dosage necessary to obtain a significant clinical, ultrasonic and biologic improvement.In the second one, 58 cases of Raynaud syndromes (47 idiopathic and 11 associated with systemic disease) were treated with 8 g daily piracetam during 6 to 12 months. A clinical and ultrasonic improvement was observed in 75 and 80 % of the cases and a normalisation of the disturb
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!